Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-DOPA PET/MRI for Hyperinsulinism
NCT05088798Phase 2Recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Sep 2020
- Primary completion
- Jan 2030
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
A Phase 2 trial of Fluorodopa F 18 in hyperinsulinism (HI), sponsored by Washington University School of Medicine. Started Sep 2020; status: recruiting.
02
Drugs
Fluorodopa F 18
03
Conditions
hyperinsulinism (HI)
Beyond the preview
Go deeper on NCT05088798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05088798.